Corrigendum: Natural History of Non-Small-Cell Lung Cancer with Bone Metastases.
作者信息
Santini Daniele, Barni Sandro, Intagliata Salvatore, Falcone Alfredo, Ferraù Francesco, Galetta Domenico, Moscetti Luca, La Verde Nicla, Ibrahim Toni, Petrelli Fausto, Vasile Enrico, Ginocchi Laura, Ottaviani Davide, Longo Flavia, Ortega Cinzia, Russo Antonio, Badalamenti Giuseppe, Collovà Elena, Lanzetta Gaetano, Mansueto Giovanni, Adamo Vincenzo, De Marinis Filippo, Satolli Maria Antonietta, Cantile Flavia, Mancuso Andrea, Tanca Francesca Maria, Addeo Raffaele, Russano Marco, Sterpi Michelle, Pantano Francesco, Vincenzi Bruno, Tonini Giuseppe
出版信息
Sci Rep. 2016 Apr 15;6:22205. doi: 10.1038/srep22205.
Abstract
摘要
相似文献
1
Corrigendum: Natural History of Non-Small-Cell Lung Cancer with Bone Metastases.
Sci Rep. 2016 Apr 15;6:22205. doi: 10.1038/srep22205.
2
Bisphosphonate use in patients with lung cancer and bone metastases: recommendations of a European expert panel.
J Thorac Oncol. 2009 Oct;4(10):1280-8. doi: 10.1097/JTO.0b013e3181b68e5a.
3
Suspected non-small cell lung cancer: incidence of occult brain and skeletal metastases and effectiveness of imaging for detection--pilot study.
Radiology. 1999 Apr;211(1):137-45. doi: 10.1148/radiology.211.1.r99ap34137.
4
Successful treatment of solitary extracranial metastases from non-small cell lung cancer.
Ann Thorac Surg. 1995 Dec;60(6):1609-11. doi: 10.1016/0003-4975(95)00760-1.
5
6
The role of whole-body bone scanning and clinical factors in detecting bone metastases in patients with non-small cell lung cancer.
Chest. 2005 Feb;127(2):449-54. doi: 10.1378/chest.127.2.449.
7
Metastases to rare locations as the initial manifestation of non-small cell lung cancer: two case reports.
Coll Antropol. 2010 Jun;34(2):609-12.
8
Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.
J Thorac Cardiovasc Surg. 2004 Jul;128(1):130-7. doi: 10.1016/j.jtcvs.2003.11.061.
9
Efficacy of bevacizumab-containing chemotherapy for non-squamous non-small cell lung cancer with bone metastases.
Cancer Chemother Pharmacol. 2013 Jun;71(6):1493-8. doi: 10.1007/s00280-013-2148-3. Epub 2013 Mar 27.
10
EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases?
Lung Cancer. 2014 Apr;84(1):86-91. doi: 10.1016/j.lungcan.2014.01.006. Epub 2014 Jan 23.
引用本文的文献
1
Survival impact of pathological fractures in metastatic cancer: a comprehensive meta-analysis.
Arch Orthop Trauma Surg. 2025 Apr 17;145(1):253. doi: 10.1007/s00402-025-05852-6.
2
Efficacy of radiotherapy combined with atezolizumab or docetaxel in patients with previously treated NSCLC.
iScience. 2024 Nov 8;27(12):111363. doi: 10.1016/j.isci.2024.111363. eCollection 2024 Dec 20.
3
Hyaluronic Acid Modified Nanostructured Lipid Carrier for Targeting Delivery of Kaempferol to NSCLC: Preparation, Optimization, Characterization, and Performance Evaluation In Vitro.
Molecules. 2022 Jul 17;27(14):4553. doi: 10.3390/molecules27144553.
4
Early Phase I Study of a Tc-Labeled Anti-Programmed Death Ligand-1 (PD-L1) Single-Domain Antibody in SPECT/CT Assessment of PD-L1 Expression in Non-Small Cell Lung Cancer.
J Nucl Med. 2019 Sep;60(9):1213-1220. doi: 10.2967/jnumed.118.224170. Epub 2019 Feb 22.
5
Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts.
Cancers (Basel). 2018 Jun 4;10(6):182. doi: 10.3390/cancers10060182.
Zotero 插件